U.S. Anesthesia and Respiratory Devices - Industry Report

The U.S. anesthesia and respiratory devices market size is calculated at USD 8,620 million in 2024 and is predicted to reach around USD 17,440 million by 2034, expanding at a CAGR of 7.3% from 2025 to 2034.

U.S. Anesthesia and Respiratory Devices Market Report Highlights

• By product, the respiratory devices segment dominated market in 2024.
• By product, the anesthesia devices segment is projected to expand rapidly in the market in the coming years.

The U.S. anesthesia and respiratory devices market is experiencing rapid growth due to the steady rise in the incidence of respiratory diseases and the increase in surgical procedures. Such devices are particularly crucial in managing chronic respiratory diseases, including COPD, asthma, and sleep apnea, and in ensuring the safe administration of anaesthesia during surgeries. Technological advancements like AI-driven respiratory support and portable home-use devices further accelerate the growth of the market. The market is thus bound to continue developing, being underpinned by ever-increasing demands for improved respiratory care solutions.

Increasing burden, such as an increasing incidence of respiratory disorders like chronic obstructive pulmonary disease (COPD), asthma, and sleep apnoea, underlines a principal driver for the U.S. anesthesia and respiratory devices market. Increasing air pollution, smoking, and an aging population have played a role in the increasing incidence of these conditions. Long-term respiratory care-bearing patients increase the demand for effective respiratory support devices such as ventilators, nebulizers, and oxygen therapy equipment. An increase in the number of surgical procedures that require operating anaesthesiologists in the U.S. is rapidly driving the market for advanced anesthesia devices. The rising prevalence of chronic diseases needing surgical intervention, including cardiovascular and neurological conditions, has led hospitals and surgical centers to accept new innovative anesthesia delivery systems. Also, advances in minimally invasive surgeries have spurred demand for precision and efficiency in these devices.

Integrating cutting-edge technologies such as AI and smart monitoring systems is revolutionizing the anaesthesia and respiratory devices market. AI-powered ventilators, real-time oxygen monitoring systems, and automated anesthesia administration solutions are enhancing patient outcomes and improving treatment efficiency. Additionally, advances in portable respiratory devices are making at-home respiratory care available and reducing hospital visits, thus improving patient convenience.

Despite the growth of the U.S. anesthesia and respiratory devices market, the high cost associated with advanced anesthesia and respiratory devices still remains a challenge. Innovative devices with AI-driven features and real-time monitoring capabilities offer high prices, which limit their accessibility, especially for smaller healthcare facilities and low-income patients. In addition, high maintenance costs and additional replacement parts will further put a strain on healthcare budgets.

Artificial intelligence (AI) is playing a transformational role in the improvement of treatment and care in the U.S. anesthesia and respiratory devices market. AI ventilators can automatically adjust oxygen levels according to the patients' real-time conditions, increasing respiratory support and lowering the responsibilities of healthcare personnel. Similarly, AI anesthesia monitoring systems enable anesthetists to deliver exact dosages of medication, lowering the chances of any complication during operations. 

The demand for portable, at-home respiratory devices has increased as a result of the growing acceptance of at-home treatment and preference for home care. Portable oxygen concentrators and CPAP machines continue to be in high demand, providing comforting respiratory support to patients with chronic conditions. The current increasing access to advanced respiratory and anesthesia devices in hospitals and outpatient care centers will provide further impetus for such demand. With government measures on the agenda to enhance rehabilitation and treatment, other healthcare programs for improvement in the respiratory sector also provide a boost to the growth of the growing U.S. anesthesia and respiratory devices market.